Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2013
11/27/2013CN102408832B Method for beaching shellac using chlorine dioxide and alcohol solvent, and application thereof
11/27/2013CN102397384B Heartleaf houttuynia herb eye drops and preparation method thereof
11/27/2013CN102038645B Desloratadine grain and preparation method thereof
11/27/2013CN102014966B Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in treatment of neoplasias
11/27/2013CN101959534B Enzyme and receptor modulation
11/27/2013CN101947205B Novel galanthamine sustained-release preparation and preparation method thereof
11/27/2013CN101632650B Self-microemulsifying semisolid skeleton capsule of daidzein and preparation method thereof
11/27/2013CN101502492B Method for preparing clarithromycin granule without bitter taste
11/26/2013US8592511 Synthesis, capping and dispersion of nanocrystals
11/26/2013US8592490 Self-microemulsifying drug delivery systems
11/26/2013US8592489 Storage-stable compositions of glycerol monoalkyl ethers
11/26/2013US8592480 Liquid compositions of calcium acetate
11/26/2013US8592372 Pharmaceutical composition and method of use to improve organ function
11/26/2013US8592369 Lactoferrin and gut neuronal health in adults and/or elderly
11/26/2013US8592365 Spacer moiety for poly(ethylene glycol) modified peptide based compounds
11/26/2013US8592210 Polyarginine-modified liposome having nuclear entry ability
11/26/2013US8591951 Tri-block copolymers for nanosphere-based drug delivery
11/26/2013US8591950 Hydrogel implants with varying degrees of crosslinking
11/26/2013US8591948 Antifungal compositions with improved bioavailability
11/26/2013US8591945 Pregelatinized starch in a controlled release formulation
11/26/2013US8591938 Liquid compositions of calcium acetate
11/26/2013US8591920 Stable lipophilic emulsions for acrylic coating and method of making
11/26/2013US8591917 Ganglioside based vaccine compositions for subcutaneous administration
11/26/2013US8591905 Nicotine immunonanotherapeutics
11/26/2013US8591904 Asymmetrically branched polymer conjugates and microarray assays
11/26/2013US8591884 Compositions and methods for enhancing metal ion dependent drug therapies
11/26/2013US8591866 Formulations decreasing particle exhalation
11/26/2013US8591864 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
11/26/2013CA2816216C Binding drugs with nanocrystalline cellulose (ncc)
11/26/2013CA2661892C Gel type enteral nutrient
11/26/2013CA2637560C Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
11/26/2013CA2623652C Antibody-drug conjugates and methods of use
11/26/2013CA2615918C Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
11/26/2013CA2608283C Pharmaceutical compositions with synchronized solubilizer release
11/26/2013CA2593908C Process for the preparation of polymer conjugates
11/26/2013CA2221690C Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
11/21/2013WO2013173834A2 Trigger-responsive chain-shattering polymers
11/21/2013WO2013173822A1 Constructs for diagnosing and treating inflammatory bowel diseases and colon cancer
11/21/2013WO2013173778A1 Methods for treating or predicting risk of a ventricular tachyarrhythmia event
11/21/2013WO2013173697A1 Orally dissolving thin films containing allergens and methods of making and use
11/21/2013WO2013173676A1 Polypeptide and lipophilic moiety conjugate compositions, formulations, and uses related thereto
11/21/2013WO2013173557A1 Nucleophilic catalysts for oxime linkage and use of nmr analyses of the same
11/21/2013WO2013173543A1 Nucleophilic catalysts for oxime linkage
11/21/2013WO2013173393A1 Drug-conjugates, conjugation methods, and uses thereof
11/21/2013WO2013173392A1 Drug-conjugates, conjugation methods, and uses thereof
11/21/2013WO2013172805A1 New orodispersible tablet formulations of olanzapine
11/21/2013WO2013172686A1 Composites of hydrophil photosensitizers for photodynamic diagnosis or treatment and biocompatible polymers
11/21/2013WO2013172669A1 Method for manufacturing nano-liposome containing nucleic acid without extrusion process
11/21/2013WO2013172627A1 Mucoadhesive nanoform microparticles
11/21/2013WO2013172586A1 Composition for improving or promoting hair growth containing, as active ingredients, photosensitizer irradiated with light and peptide, and method using same
11/21/2013WO2013172472A1 Sheet molding and hemostatic material
11/21/2013WO2013172467A1 Radiation-sterilization-resistant protein composition
11/21/2013WO2013172358A1 Functional compound, molecular assembly containing functional compound, composition containing molecular assembly, kit, and use of molecular assembly, composition or kit
11/21/2013WO2013172297A1 Preparation containing 6,7-unsaturated-7-carbamoylmorphinan derivative
11/21/2013WO2013172292A1 Aqueous gel
11/21/2013WO2013171146A1 Oral film containing enteric release opiate resinate
11/21/2013WO2013170862A1 Substrate mediated enzymes prodrug therapy
11/21/2013WO2013170408A1 Tat ptd-endostatin recombinant protein, preparation method and application thereof
11/21/2013WO2013170386A1 Oligonucleotide chelate complex-polypeptide compositions and methods
11/21/2013WO2013170317A1 Liquid formulation
11/21/2013WO2013128419A3 Pharmaceutical compositions comprising boronic acid compounds
11/21/2013WO2013119144A3 Hair growth agent (embodiments) and method for treating hair loss
11/21/2013WO2013116175A3 Reduced sugar syrups and methods of making reduced sugar syrups
11/21/2013WO2013106577A3 Enhancement of transport of therapeutic molecules across the blood brain barrier
11/21/2013WO2012142245A8 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
11/21/2013US20130310462 Supramolecular complexes of polyanionic polymers and spermidine in tissue maintenance and repair
11/21/2013US20130310420 Stable formulations of pitavastatin
11/21/2013US20130310355 Low toxicity topical active agent delivery system
11/21/2013US20130310337 Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha
11/21/2013US20130310335 Prolonged release bioadhesive therapeutic systems
11/21/2013US20130309338 Biologically active substance-containing water-solubilizing preparation and method for producing the same
11/21/2013US20130309318 Stable silver oxide formulations
11/21/2013US20130309314 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
11/21/2013US20130309312 Dermal composition comprising polymeric reversed micelle, and method for producing same
11/21/2013US20130309311 Pellet formulation for the treatment of the intestinal tract
11/21/2013US20130309307 Bilayer Pharmaceutical Tablet Comprising Telmisartan and a Diuretic and Preparation Thereof
11/21/2013US20130309277 Polymer micelles containing anthracyclines for the treatment of cancer
11/21/2013US20130309270 Vaccines comprising bisphosphonate and methods of use thereof
11/21/2013US20130309257 Thiazolidine Linker for the Conjugation of Drugs to Antibodies
11/21/2013US20130309218 Process for producing aqueous solution containing fat-soluble substance
11/21/2013US20130309215 Pharmaceutical composition
11/21/2013US20130309192 Auristatin Compounds and Conjugates Thereof
11/21/2013US20130309175 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
11/21/2013US20130309174 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
11/21/2013US20130309171 Pre-targeted nanoparticle system and method for labeling biological particles
11/21/2013DE102012009572A1 Agent, used to treat aquatic living beings against diseases caused by parasites, bacteria, fungi and viruses, comprises glycerol-formal or glycerol-formal containing compounds for formulating water-insoluble or poorly water-soluble drugs
11/20/2013EP2664347A1 Method for treating atrophic age related macular degeneration
11/20/2013EP2664343A2 Suppression of cancer
11/20/2013EP2664340A2 A direct drug delivery system based on thermally responsive biopolymers
11/20/2013EP2664339A2 YopM as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions
11/20/2013EP2664328A1 Omega3 fatty acid compound preparation
11/20/2013EP2664324A1 Nanocapsules with a polymer shell
11/20/2013EP2664321A2 Medical instrument
11/20/2013EP2663338A2 Oligosaccharide conjugates for targeting bacteria and uses related thereto
11/20/2013EP2663337A2 Method for delivering agents into cells using bacterial toxins
11/20/2013EP2663336A1 Methods and reagents for efficient and targeted delivery of therapeutic molecules to cxcr4 cells
11/20/2013EP2663293A2 Triggered polymer viscous pill and methods of using the same
11/20/2013EP2663287A1 Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
11/20/2013EP2663285A2 Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
11/20/2013EP2663283A1 High drug load tablet formulation of brivanib alaninate
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 1712